141 related articles for article (PubMed ID: 9720472)
1. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study.
Krcméry V; Spanik S; Krupova I; Trupl J; Kunova A; Smid M; Pichnova E
J Chemother; 1998 Aug; 10(4):320-5. PubMed ID: 9720472
[TBL] [Abstract][Full Text] [Related]
2. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study.
Spanik S; Krupova I; Trupl J; Kunová A; Novotny J; Mateicka F; Pichnova E; Sulcova M; Sabo A; Jurga L; Krcmery V
J Infect Chemother; 1999 Sep; 5(3):180-184. PubMed ID: 11810513
[TBL] [Abstract][Full Text] [Related]
3. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
Shi SH; Kong HS; Xu J; Zhang WJ; Jia CK; Wang WL; Shen Y; Zhang M; Zheng SS
Transpl Infect Dis; 2009 Oct; 11(5):405-12. PubMed ID: 19638006
[TBL] [Abstract][Full Text] [Related]
7. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
[TBL] [Abstract][Full Text] [Related]
8. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
9. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
[TBL] [Abstract][Full Text] [Related]
10. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
11. Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.
Spanik S; Trupl J; Ilavska I; Helpianska L; Drgona L; Demitrovicova A; Kukuckova E; Studena M; Pichna P; Oravcova E; Rusnakova V; Koren P; Lacka J; Krcmery V
J Chemother; 1996 Oct; 8(5):387-93. PubMed ID: 8957720
[TBL] [Abstract][Full Text] [Related]
12. Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Krupova Y; Novotny J; Sabo A; Mateicka F; Krcmery V
Int J Antimicrob Agents; 1998 Nov; 10(4):313-6. PubMed ID: 9916907
[TBL] [Abstract][Full Text] [Related]
13. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
14. Bacteremia in patients with hematological malignancies.
Wang FD; Lin ML; Liu CY
Chemotherapy; 2005 May; 51(2-3):147-53. PubMed ID: 15886475
[TBL] [Abstract][Full Text] [Related]
15. Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.
Nouér SA; Nucci M; Anaissie E
Expert Rev Hematol; 2015 Oct; 8(5):647-58. PubMed ID: 26115679
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
[TBL] [Abstract][Full Text] [Related]
18. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883
[TBL] [Abstract][Full Text] [Related]
19. [Etiology of bacterial infections in febrile neutropenic patients: the role of the laboratory in the diagnosis].
Poyart C; Morand P; Buzyn A
Presse Med; 2004 Apr; 33(7):460-6. PubMed ID: 15105768
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes.
Spanik S; Sufliarsky J; Mardiak J; Sorkovska D; Trupl J; Kunova A; Kukuckova E; Rusnakova V; Demitrovicova A; Pichna P; Krupova I; Kralovicova K; Mateićka F; West D; Krcmery V
Support Care Cancer; 1998 May; 6(3):291-4. PubMed ID: 9629885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
